Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Advanced patent CN103304550B details high-yield Olmesartan Medoxomil synthesis. Delivers supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering reliable supply chain solutions.
Novel nickel-catalyzed method offers cost reduction in pharma intermediates manufacturing with scalable one-pot synthesis for high-purity aryl alkenyl sulfoxide.
Patent CN112479993A details a cost-effective iron-catalyzed synthesis for KRAS inhibitor intermediates, offering significant supply chain and purity advantages for API manufacturers.
Patent CN105175327B reveals AgOTf catalyzed quinoline synthesis offering high purity and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN110683926B reveals a robust Pd-catalyzed method for direct C-O coupling, offering high yields and broad substrate scope for reliable pharmaceutical intermediate manufacturing.
Novel Mo/Cu co-catalyzed method for high-purity triazole intermediates. Reduces steps and costs for API manufacturing with mild conditions.
Patent CN110467555B reveals a chiral phosphoric acid catalyzed route for high-purity axial chiral aryl indoles, offering cost-effective API intermediate manufacturing.
Patent CN114195711B reveals efficient Pd-catalyzed carbonylation. Delivers high-purity quinoline-4(1H)-one with substantial cost reduction and supply chain reliability.
Novel nickel-catalyzed carbonylation method for indole synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediates.
Metal-free heating method for quinoline intermediates. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Novel Pd-catalyzed carbonylation method offers high yields and broad substrate scope for cost-effective API intermediate manufacturing.
Patent CN113845481A details a copper-catalyzed route to pyridazinone intermediates, offering safer alternatives to hydrazine for reliable pharmaceutical manufacturing.
Patent CN104447440B reveals Mn-catalyzed asymmetric oxidation. High purity, green process, supply chain reliability for pharma intermediates.
Novel one-pot synthesis for 9H-pyrimido[4,5-b]indoles using copper catalysis. Reduces steps and cost for pharmaceutical intermediates.
Patent CN114539198B reveals a novel Pd-catalyzed route for chroman amides, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN105061325A details aqueous Pd/C catalysis for high-purity biaryl benzimidazole intermediates ensuring supply chain stability and significant cost reduction in pharmaceutical intermediates manufacturing.
Patent CN118619879A reveals a novel Rh-catalyzed method for trifluoromethyl enaminones. Achieve cost reduction in pharmaceutical intermediates manufacturing with scalable processes.
Patent CN113461589B details a novel one-step asymmetric Friedel-Crafts reaction for chiral 2,3-disubstituted indoleamines, offering significant cost reduction in API manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of indoxazinones with high enantioselectivity and mild conditions for anticancer drug development.